USPSTF Final Recommendation on Aspirin for Primary CV Preven

The Task Force advises against starting aspirin for primary prevention in people aged 60 years or over and suggests the decision should be individualized in those aged 40-59.

Related Keywords

Colorado , United States , Boston , Massachusetts , National Jewish Health , Denver , American , Michael Barry , Andrew Freeman , Allans Brett , Decisions Program , American College Of Cardiology , Journal Of The American Medical Association , Us Preventive Services Task Force , Task Force Statement , Health Decision Sciences Center At Massachusetts , University Of Colorado School Medicine , Us Congress , Agency For Healthcare Research , Services Task Force , American Medical , Task Force , Informed Medical Decisions Program , Health Decision Sciences Center , Massachusetts General Hospital , Medscape Cardiology , Colorado School , Evidence Review , American College , Healthcare Research , Force Statement , Modeling Study , Patient Page , Cv , Ardiovascular , Aspirin , Myocardial Infarction , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Antiplatelet Agent , Antiplatelet Agent Related Bleeding , Ntiplatelet Therapy Related Hemorrhage , Cardiovascular Disease , Vd Cardiovascular Disease , Hemorrhage , Bleeding , Gastrointestinal Hemorrhage , Gastrointestinal Bleeding , Leeding Gastrointestinal , Surgery , Brain Hemorrhage , Rain ,